Trends and drivers (continued) in medical technology

 More medtech trends

  • Nanotechnology advances.  The use of nanotechnology in medicine has faced as many overblown promises as any other application of nanotechnology. However, any realistic view of future medical technologies with big impact would be amiss if it did not consider the myriad applications of "nanotechnology", which we place in quotes to denote that there is no one technology called nanotechnology.  Rather, nanotechnology emcompasses a huge variation of technologies whose common denominator is only their design, manufacture or effects at a very small size.  Drug delivery, coatings technologies, angiogenesis and countless other unrelated technologies fall within the definition of nanotechnology.  Some, or many, may succeed hugely.
     
  • Developments in tissue engineering.  Setting aside, for the moment, the heated vitriol of the (current)  federal ban on funding for embrionic stem cell research, the continued developmet of cell biology applied to therapeutics in the broader category of cell and tissue engineering is a major trend that is creating new therapeutics.  Wound management, trauma treatments, organ repair/reconstruction, and others are established, rapidly growing markets.  Now, add back stem cell therapy (embrionic or otherwise) and you can see the enormity of this trend.
     
  • Gene therapy developments.  Forever an area of enormous potential, exceeded only by the overblown assessments of how soon developments will be commercialized, gene therapy developments continue to inch closer to reality.  While these technologies, too numerous in their diversity to mention, remain predominantly in the realm of research, the potential they hold and the rate of technology advance toward realizing that potential in virtually every organ system and clinical applications makes ignoring them a foolhardy consideration by any medtech manufacturer.
     

To be continued…

 

 

 

Leave a Reply